Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Closed Grad­u­at­ed Plan Pro­ce­dures and Notifications

An overview of the closed graduated plan procedures is available in German.

Abgeschlossene Verfahren / Bescheide

Closed graduated plan procedures for which English documents are available

DateTitel
07.01.2013Implementation of minimum standards for blood screening tests
Decision
21.12.2011Hearing for the purpose of safeguarding the quality of blood screening tests
Hearing
26.03.2010Supplementary statement concerning state of the art of blood screening tests
Supplementary Statement
20.01.2010Scientific exchange of information for the purpose of safeguarding the quality standard of blood screening tests
Scientific exchange of information

Graduated Plan Procedure (Stufenplan) - Explanation

The general administrative regulation on the graduated plan procedure ("Stufenplan", 9 Feb 2005), according to §63 AMG, specifies the details of the cooperation and coordination between the competent federal authorities and additional authorities and services involved, the participation of the pharmaceutical entrepreneur, the procedures at the various danger levels as well as lines of communication in connection with risks associated with medicinal products. Depending on the risk level, the competent federal authority performs an information exchange with (Stage 1) or a hearing of (Stage 2) the concerned pharmaceutical entrepreneurs/ marketing authorisation holders regarding an intended measure for the purpose of risk prevention.

Donor Selection and Donor Questionnaire

A donor questionnaire is an important part of the donor selection process that ensures a high level of safety of blood-derived medicinal products. A uniform, national donor questionnaire has been developed by an expert group in Germany, which covers the eligibility criteria for donors as laid down in the German Hemotherapy Guidelines and has been evaluated in a field test.

Updated: 21.11.2019